Funder: Roche
Due Dates: Rolling (at least 60 days before start) | November 26, 2026 (system closes, 12:00 AM PT) | January 4, 2027 (system reopens) | March 4, 2027 (earliest start after reopening)
Funding Amounts: Project-specific grants: indirect costs capped at 25% of the total payment
Summary: Genentech supports health, patient, science, education, and community initiatives through year-round invitations and limited rolling grants.
Key Information: Only a targeted number of rolling submissions aligned with Genentech’s strategic giving priorities receive funding.
Description
Genentech, whose parent company is Roche, supports programs, projects, and events aligned with its strategic grantmaking priorities. Its giving encompasses health, patients, and science; K–12 and higher education; and community giving. The program extends funding invitations throughout the year and reviews and awards a targeted number of rolling submissions. This support is distinct from Genentech’s requests for proposals, which actively solicit projects addressing specific objectives.
Genentech’s philanthropic work aims to strengthen healthcare and education, foster innovation, and support sustainable solutions. Its priorities include local partnerships that help communities thrive and access to educational and career pathways in life sciences and medicine. Programs, projects, and events are typically US-based, with additional consideration for community requests in locations where Genentech has a presence.
